According to Dynavax Technologies 's latest financial reports the company's current EPS (TTM) is $1.86. In 2022 the company made an earnings per share (EPS) of $2.31 an increase over its 2021 EPS that were of $0.61.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $1.86 | -19.48% |
2022 | $2.31 | 278.69% |
2021 | $0.61 | -178.21% |
2020 | -$0.78 | -64.71% |
2019 | -$2.21 | -13.33% |
2018 | -$2.55 | 38.59% |
2017 | -$1.84 | -36.77% |
2016 | -$2.91 | -11.55% |
2015 | -$3.29 | -4.64% |
2014 | -$3.45 | |
2012 | -$4.10 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() Pfizer PFE | $5.18 | 178.49% | ๐บ๐ธ USA |
![]() Amgen AMGN | $14.81 | 696.24% | ๐บ๐ธ USA |
![]() Biogen BIIB | $21.62 | 1,062.37% | ๐บ๐ธ USA |
![]() Gilead Sciences GILD | $4.46 | 139.78% | ๐บ๐ธ USA |
![]() Merck MRK | $5.73 | 208.06% | ๐บ๐ธ USA |
![]() AstraZeneca AZN | $1.52 | -18.55% | ๐ฌ๐ง UK |
![]() GlaxoSmithKline GSK | $8.03 | 331.84% | ๐ฌ๐ง UK |
![]() Agenus
AGEN | $0.21 | -88.71% | ๐บ๐ธ USA |
![]() Teva Pharmaceutical Industries TEVA | -$2.12 | -213.98% | ๐ฎ๐ฑ Israel |